Effects of spinach nitrate on insulin resistance, endothelial dysfunction markers and inflammation in mice with high-fat and high-fructose consumption

References

• Brown AE, Walker M. Genetics of insulin resistance and the metabolic syndrome. Curr Cardiol Rep. 2016; 18: 1–8.
   Web of Science ®Google Scholar
• Prasad DS, Kabir Z, Dash AK, Das BC. Prevalence and risk factors for metabolic syndrome in Asian Indians: a community study from urban eastern India. J Cardiovasc Dis Res. 2012; 3: 204–11.
   PubMedGoogle Scholar
• Ford ES, Li C, Zhao G, Pearson WS, Mokdad AH. Prevalence of the metabolic syndrome among US adolescents using the definition from the International Diabetes Federation. Diabetes Care. 2008; 31: 587–9.
   Web of Science ®Google Scholar
• Cersosimo E, DeFronzo RA. Insulin resistance and endothelial dysfunction: the road map to cardiovascular diseases. Diabetes Metab Res Rev. 2006; 22: 423–36.
   PubMed Web of Science ®Google Scholar
• Dandona P, Aljada A, Chaudhuri A, Mohanty P, Garg R. Metabolic syndrome: a comprehensive perspective based on interactions between obesity, diabetes, and inflammation. Circulation. 2005; 111: 1448–54.
   PubMed Web of Science ®Google Scholar
• Steinberg HO, Chaker H, Leaming R, Johnson A, Brechtel G, Baron AD. Obesity/insulin resistance is associated with endothelial dysfunction. Implications for the syndrome of insulin resistance. J Clin Invest. 1996; 97(11): 2601–10.
   PubMed Web of Science ®Google Scholar
• Sola S, Mir MQ, Cheema FA, Khan-Merchant N, Menon RG, Parthasarathy S, etal. Irbesartan and lipoic acid improve endothelial function and reduce markers of inflammation in the metabolic syndrome: results of the irbesartan and lipoic acid in endothelial dysfunction (ISLAND) study. Circulation. 2005; 111: 343–8.
   PubMed Web of Science ®Google Scholar
• Lundberg JO, Feelisch M, Björne H, Jansson EA, Weitzberg E. Cardioprotective effects of vegetables: is nitrate the answer?. Nitric Oxide. 2006; 15: 359–62.
   PubMed Web of Science ®Google Scholar
• Machha A, Schechter AN. Inorganic nitrate: a major player in the cardiovascular health benefits of vegetables?. Nutr Rev. 2012; 70: 367–72.
   Web of Science ®Google Scholar
• Kapil V, Milsom AB, Okorie M, Maleki-Toyserkani S, Akram F, Rehman F, etal. Inorganic nitrate supplementation lowers blood pressure in humans: role for nitrite-derived NO. Hypertension. 2010; 56: 274–81.
   PubMed Web of Science ®Google Scholar
• Bryan NS, Calvert JW, Elrod JW, Gundewar S, Ji SY, Lefer DJ. Dietary nitrite supplementation protects against myocardial ischemia-reperfusion injury. Proc Natl Acad Sci USA. 2007; 104: 19144–9.
   PubMed Web of Science ®Google Scholar
• Carlström M, Larsen FJ, Nyström T, Hezel M, Borniquel S, Weitzberg E, etal. Dietary inorganic nitrate reverses features of metabolic syndrome in endothelial nitric oxide synthase-deficient mice. Proc Natl Acad Sci USA. 2010; 107: 17716–20.
   PubMed Web of Science ®Google Scholar
• Gilchrist M, Shore AC, Benjamin N. Inorganic nitrate and nitrite and control of blood pressure. Cardiovasc Res. 2011; 89: 492–8.
   PubMed Web of Science ®Google Scholar
• Hord NG, Tang Y, Bryan NS. Food sources of nitrates and nitrites: the physiologic context for potential health benefits. Am J Clin Nutr. 2009; 90: 1–10.
   PubMed Web of Science ®Google Scholar
• Santamaria P. Nitrate in vegetables: toxicity, content, intake and EC regulation. J Sci Food Agric. 2006; 86: 10–17.
   Web of Science ®Google Scholar
• Yang X, Bondonno CP, Indrawan A, Hodgson JM, Croft KD. An improved mass spectrometry-based measurement of NO metabolites in biological fluids. Free Radic Biol Med. 2013; 56: 1–8.
   PubMed Web of Science ®Google Scholar
• Bondonno CP, Yang X, Croft KD, Considine MJ, Ward NC, Rich L. Flavonoid-rich apples and nitrate-rich spinach augment nitric oxide status and improve endothelial function in healthy men and women: a randomized controlled trial. Free Radic Biol Med. 2012; 52: 95–102.
   PubMed Web of Science ®Google Scholar
• Makni M, Fetoui H, Garouiel M, Gargouri NK, Jaber H, Makni J, etal. Hypolipidemic and hepatoprotective seeds mixture diet rich in ω-3 and ω-6 fatty acids. Food Chem Toxicol. 2010; 48: 2239–46.
   PubMed Web of Science ®Google Scholar
• Tappy L, Lê KA, Tran C, Paquot N. Fructose and metabolic diseases: new findings, new questions. Nutrition. 2010; 26: 1044–9.
   PubMed Web of Science ®Google Scholar
• Jaya C, Anuradha CV. Cissus quadrangularis stem alleviates insulin resistance, oxidative injury and fatty disease in rats fed high fat plus fructose diet. Food Chem Toxicol. 2010; 48: 2021–9.
   PubMed Web of Science ®Google Scholar
• Comporti M, Signorini C, Arezzini B, Vecchio D, Monaco B, Gardi C. F2-isoprostanes are not just markers of oxidative stress. Free Radic Biol Med. 2008; 44: 247–56.
   PubMed Web of Science ®Google Scholar
• Lundberg JO, Carlström M, Larsen FJ, Weitzberg E. Roles of dietary inorganic nitrate in cardiovascular health and disease. Cardiovasc Res. 2011; 89: 525–32.
   PubMed Web of Science ®Google Scholar
• Mirvish SS. Role of N-nitroso compounds (NOC) and N-nitrosation in etiology of gastric, esophageal, nasopharyngeal and bladder cancer and contribution to cancer of known exposures to NOC. Cancer Lett. 1995; 93: 17–48.
   PubMed Web of Science ®Google Scholar
• Kevil CG, Lefer DJ. Review focus on inorganic nitrite and nitrate in cardiovascular health and disease. Cardiovasc Res. 2011; 89: 489–91.
   PubMed Web of Science ®Google Scholar
• Sydow K, Mondon CE, Cooke JP. Insulin resistance: potential role of the endogenous nitric oxide synthase inhibitor ADMA. Vasc Med. 2005; 10(Suppl 1): S35–43.
   Google Scholar
• Lidder S, Webb AJ. Vascular effects of dietary nitrate (as found in green leafy vegetables and beetroot) via the nitrate–nitrite–nitric oxide pathway. Br J Clin Pharmacol. 2012; 75: 677–96.
   Web of Science ®Google Scholar
• Correia M, Barroso Â, Barroso MF, Soares D, Oliveirab M, Delerue-Matos C. Contribution of different vegetable types to exogenous nitrate and nitrite exposure. Food Chem. 2010; 120: 960–6.
   Web of Science ®Google Scholar
• Lundberg JO, Weitzberg E, Gladwin MT. The nitrate-nitrite-nitric oxide pathway in physiology and therapeutics. Nat Rev Drug Discov. 2008; 7: 156–67.
   PubMed Web of Science ®Google Scholar
• Zhang ZH, Wang ZQ, Yang Z, Niu YX, Zhang WW, Li XY, etal. A novel mice model of metabolic syndrome: the high-fat–high-fructose diet-fed ICR mice. Exp Anim. 2015; 64(4): 435–42.
   PubMed Web of Science ®Google Scholar
• Poudyal H, Panchal S, Brown L. Comparison of purple carrot juice and β-carotene in a high-carbohydrate, high-fat diet-fed rat model of the metabolic syndrome. Br J Nutr. 2010; 104: 1322–32.
   PubMed Web of Science ®Google Scholar
• Wada T, Kenmochi H, Miyashita Y, Sasaki M, Ojima M, Sasahara M, etal. Spironolactone improves glucose and lipid metabolism by ameliorating hepatic steatosis and inflammation and suppressing enhanced gluconeogenesis induced by high-fat and high-fructose diet. Endocrinology. 2010; 151: 2040–9.
   PubMed Web of Science ®Google Scholar
• Miatello R, Vázquez M, Renna N, Cruzado M, Zumino AP, Risler N. Chronic administration of resveratrol prevents biochemical cardiovascular changes in fructose-fed rats. Am J Hypertens. 2005; 18: 864–70.
   PubMed Web of Science ®Google Scholar
• Axelsen LN, Pedersen HD, Petersen JS, Holstein-Rathlou NH, Kjølbye AL. Metabolic and cardiac changes in high cholesterol–fructose-fed rats. J Pharmacol Toxicol Methods. 2010; 61: 292–6.
   Web of Science ®Google Scholar
• Chidambaram J, Carani VA. Cissus quadrangularis stem alleviates insulin resistance, oxidative injury and fatty liver disease in rats fed high fat plus fructose diet. Food Chem Toxicol. 2010; 48: 2021–9.
   PubMed Web of Science ®Google Scholar
• Lehnen AM, Rodrigues B, Irigoyen MC, De Angelis K, Schaan BD. Cardiovascular changes in animal models of metabolic syndrome. J Diabetes Res. 2013; 2013: 761314.
   Web of Science ®Google Scholar
• Stoner L, Lucero AA, Palmer BR, Jones LM, Young JM, Faulkner J. Inflammatory biomarkers for predicting cardiovascular disease. Clin Biochem. 2013; 46: 1353–71.
   PubMed Web of Science ®Google Scholar
• Patterson CC, Smith AE, Yarnell JW, Rumley A, Ben-Shlomo Y, Lowe GD. The associations of interleukin-6 (IL-6) and downstream inflammatory markers with risk of cardiovascular disease: the Caerphilly Study. Atherosclerosis. 2010; 209: 551–7.
   Web of Science ®Google Scholar
• Nishida H, Horio T, Suzuki Y, Iwashima Y, Tokudome T, Yoshihara F, etal. Interleukin-6 as an independent predictor of future cardiovascular events in high-risk Japanese patients: comparison with C-reactive protein. Cytokine. 2012; 53: 342–6.
   Web of Science ®Google Scholar
• Al-Aly Z, Pan H, Zeringue A, Xian H, McDonald JR, El-Achkar TM, etal. Tumor necrosis factor-α blockade, cardiovascular outcomes, and survival in rheumatoid arthritis. Transl Res. 2011; 157: 10–18.
   PubMed Web of Science ®Google Scholar
• Diamant M, Lamb HJ, van de Ree MA, Endert EL, Groeneveld Y, Bots ML, etal. The association between abdominal visceral fat and carotid stiffness is mediated by circulating inflammatory markers in uncomplicated type 2 diabetes. J Clin Endocrinol Metab. 2005; 90: 1495–501.
   PubMed Web of Science ®Google Scholar
• Ritchie SA, Connell JM. The link between abdominal obesity, metabolic syndrome and cardiovascular disease. Nutr Metab Cardiovasc Dis. 2007; 17: 319–26.
   PubMed Web of Science ®Google Scholar
• Bourque SL, Davidge ST, Adams MA. The interaction between endothelin-1 and nitric oxide in the vasculature: new perspectives. Am J Physiol Regul Integr Comp Physiol. 2011; 300: R1288–95.
   PubMed Web of Science ®Google Scholar
• Böhm F, Pernow J. The importance of endothelin-1 for vascular dysfunction in cardiovascular disease. Cardiovasc Res. 2007; 76: 8–18.
   PubMed Web of Science ®Google Scholar